n-CPAP使用者に対するUPPPの効果 The Effect of UPPP in Obstructive Sleep Apnea Hypopnea Patients Intolerant of Continuous Positive Airway Pressure Treatment

この論文にアクセスする

この論文をさがす

著者

抄録

Recently, a consensus that nasal continuous positive airway pressure (n-CPAP) treatment is the first choice therapy for severe Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS). However, it is also recognized that n-CPAP is an imperfect therapy and many patients find this treatment intolerable. In this study, four severe n-CPAP intolerant OSAHS patients, with a shallow oropharyngeal space, surrounded by large uvula and enlarged tonsils recieved Uvulopalatopharyngoplasty (UPPP) to decrease the pressure, and then remove n-CPAP. We also encouraged the patients to lose weight. After the operation, sleep apnea hypopnea improved in all the patients, two of whom could remove n-CPAP completely and two of whom continued to use n-CPAP at a lower pressure level. UPPP is an effective treatment for patients with a shallow oropharyngeal space who are unable to tolerate n-CPAP because of its side effects.

収録刊行物

  • 耳鼻咽喉科臨床

    耳鼻咽喉科臨床 94(1), 39-42, 2001-01-01

    The Society of Practical Otolaryngology

参考文献:  15件中 1-15件 を表示

被引用文献:  2件中 1-2件 を表示

各種コード

  • NII論文ID(NAID)
    10008095562
  • NII書誌ID(NCID)
    AN00107089
  • 本文言語コード
    JPN
  • 資料種別
    NOT
  • ISSN
    00326313
  • データ提供元
    CJP書誌  CJP引用  J-STAGE 
ページトップへ